Inspiration Biopharmaceuticals
Laguna Niguel
About Inspiration Biopharmaceuticals
Inspiration Biopharmaceuticals, Inc. develops recombinant blood coagulation factor products for the treatment of hemophilia. Its product candidates include IB1001, an intravenous recombinant factor IX for the acute and preventative treatment of bleeding in individuals with hemophilia B; and OBI-1, an intravenous recombinant porcine factor VIII (FVIII) for the treatment of individuals who have developed inhibitors against human FVIII and for individuals with acquired hemophilia A. The company also has preclinical programs that focus on human recombinant factor VIIa for individuals with either hemophilia A or B who have developed inhibitors, and individuals with factor VII deficiency; human recombinant FVIII to treat individuals with hemophilia A. Inspiration Biopharmaceuticals has a strategic partnership with Ipsen SA. The company was founded in 2004 and is based in Laguna Niguel, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $258.6M
- Last round: Series Unknown (Mar 2011)
- Website: inspirationbio.com
- Phone: 617-588-1800
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inspiration-biopharmaceuticals-2420992 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.